Another new drug canagliflozin has been approved for the treatment of diabetes in the UK. This is a new class of anti-diabetic medication that has joined the existing armory of oral agents in treatment of diabetes. Very soon, the drug will be available in Singapore similarly. The potential market for type 2 diabetes drugs is enormous and growing. An estimated 382 million people worldwide have diabetes, according to the International Diabetes Federation, with numbers set to worsen in many countries with aging population and increasing prevalence of obesity. While the addition of new treatment for diabetes is welcome, no drug is perfect enough to be a miracle panacea for the treatment of diabetes. Successful management of diabetes requires the concerted effort of appropriate medications, the sound clinical judgement of an astute physician, conscientious lifestyle modifications, consistent dietary habits, and most importantly, the patients’ motivation and desire to control their diabetes well.